Start your Trading & Investing Journey with us

Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates

Nephrocare Health Services IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details

Nephrocare Health Services IPO Review

Nephrocare Health Services Limited is India’s largest dialysis service provider, operating 519 clinics across India, Nepal, the Philippines and Uzbekistan as of September 30, 2025 . The company earns revenue through in-clinic dialysis, off-clinic dialysis solutions, PPP dialysis centres, consumables distribution and international operations. Its services are used by chronic kidney disease (CKD) patients requiring regular hemodialysis, delivered through asset-light, high-efficiency centres integrated with hospitals and state PPP models.


The Company is led by Promoter, i.e., VIKRAM VUPPALA, BESSEMER VENTURE PARTNERS TRUST, EDORAS INVESTMENT HOLDINGS PTE. LTD., HEALTHCARE PARENT LIMITED,

The Revenues from operations for the Period ended on Sep 30 2025, and Fiscals ended on Mar 31, 2025, 2024 and 2023 were â‚¹ 4,839.66 Million, ₹ 7,699.15 Million, â‚¹ 5,747.22 Million, and ₹ 4,432.59 Million, The EBITDA for the Period ended on Sep 30 2025, and Fiscals ended on Mar 31, 2025, 2024 and 2023 were â‚¹ 1,103.10 Million, ₹

© 2022 CA Abhay Varn. All Rights Reserved Abhayvarn.com